IRADIMED CORP - Common Stock (IRMD)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
4,511,673
Share change
+427,051
Total reported value
$104,727,212
Price per share
$23.21
Number of holders
64
Value change
+$10,282,835
Number of buys
41
Number of sells
26

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2020

As of 30 Jun 2020, IRADIMED CORP - Common Stock (IRMD) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,511,673 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Nine Ten Capital Management LLC, VANGUARD GROUP INC, Russell Investments Group, Ltd., Ranger Investment Management, L.P., RK Capital Management, LLC, Soleus Capital Management, L.P., Mondrian Investment Partners LTD, and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 64 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.